AbSci Corporation (ABSI)

[crudeoil24]

Recent IPO > Absci Corporation, formerly AbSci LLC, is a synthetic biology company. The Company with its artificial intelligence (AI)-powered integrated drug creation platform enables the creation of protein-based drugs (biologics) by unifying biologic drug discovery and cell line development processes into one process. It uses synthetic biology technologies and deep learning AI to predict, identify, design, construct, screen, select and scale production of biologic drug candidates, and learn from the data it generates. The Company has drug candidates in approximately nine active programs, eight of the active programs are focused on developing production cell lines for drug candidates. It has one discovery program, focused on lead optimization with Astellas. Its active programs include Bispecific mAb, Bispecific T-cell engager, Cytokine, Fab, Multivalent Fc-fusion, Plasma protein and mAb.